S158: final result of tki discontinuation trial with dasatinib for second attempt of treatment free remission after failing first attempt with imatinib: treatment-free remission accomplished by dasatinib

HemaSphere(2022)

引用 0|浏览2
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要